News iX Biopharma Ltd.

Equities

42C

SG1BD9000009

Market Closed - Singapore S.E. Other stock markets 05:04:23 2024-04-22 am EDT			5-day change	1st Jan Change
0.043 ^SGD	+7.50%		0.00%	-4.44%

Mar. 12	Singaporean Shares End Marginally Higher; Biopharma's Shares Climb 2% on Introduction of New Sublingual Wafer	MT
Mar. 12	IX Biopharma Introduces New Sublingual Wafer	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Singaporean Shares End Marginally Higher; Biopharma's Shares Climb 2% on Introduction of New Sublingual Wafer	Mar. 12	MT
IX Biopharma Introduces New Sublingual Wafer	Mar. 12	MT
IX Biopharma Ltd. Announces Development of Semaglutide Sublingual Wafer, Ixb 401, Targeting Diabetes and Obesity Markets	Mar. 11	CI
Singapore Stocks Linger in Red; IX Biopharma's Shares Soar 12% Following Unveiling of Novel Drug Delivery System	Mar. 05	MT
IX Biopharma Unveils Novel Drug Delivery System; Shares Surge 12%	Mar. 04	MT
Singapore Stocks Open on Monday in Red; IX Biopharma’s Stock Plunge 9% Following Contract Termination	Mar. 04	MT
IX Biopharma Ltd. Unveils Novel NAD Wafers At the Centre for Healthy Longevity Conference 2024	Mar. 04	CI
IX Biopharma’s Subsidiary Issues Termination Notice for Licensing Agreement; Shares Plunge 9%	Mar. 03	MT
IX Biopharma Stays in Red in Fiscal H1	Feb. 06	MT
IX Biopharma Ltd. Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 05	CI
IX Biopharma Unit Ends Wafermine Licensing Deal with Seelos Therapeutics; Shares Tumble 10%	Nov. 20	MT
IX Biopharma Unit Launches Anti Ageing Products in US	23-10-02	MT
IX Biopharma Ltd Announces its Wholly-Owned Subsidiary, Meltmed Inc, Introduces its New Suite of Fast-Dissolving Wafer Products in United States	23-09-29	CI
Singapore Stocks Snap Losing Streak; Oxley Shares Slip 4% on Expected Losses in Fiscal H2, Fiscal 2023	23-08-22	MT
IX Biopharma Trims Losses in Fiscal H2; Shares Jump 17%	23-08-22	MT
IX Biopharma Ltd. Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-21	CI
IX Biopharma Limited Unveils Development of Interferon Wafer to Complement Respiratory Viral Diseases	23-08-15	CI
IX Biopharma Ltd. Announces Change of Registered Office Address	23-08-04	CI
IX Biopharma Issues SG$2 Million Worth of Convertible Bonds to Private Investor	23-07-25	MT
IX Biopharma Ltd. announced that it has received SGD 2 million in funding	23-07-23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News iX Biopharma Ltd.

Equities

42C

SG1BD9000009

Summary

Filters